009: CMC Considerations For In-Human Studies with Drs. Edith Perez & Nathan Ihle

Sep 21, 2020 · 45 min · 32.6 MB

0:00-45:17

Streams straight from the publisher. podnod never proxies or re-hosts episode audio.

We love to hear from our listeners. Send us a message.

Bolt Biotherapeutics CMO Dr. Edith Perez and VP of CMC & Quality Dr. Nathan Ihle bring a unique combination of patient and production process expertise to the table for an enlightening conversation on preparing chemistry, manufacturing, and controls for an IND and ensuing first in-human studies.

Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.

Subscribe to our monthly Business of Biotech newsletter.

Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.com

Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/